Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis

被引:0
|
作者
Rondepierre, Fabien [1 ]
Tauveron-Jalenques, Urbain [2 ]
Valette, Solene [2 ]
Mulliez, Aurelien [3 ]
D'Incan, Michel [4 ]
Lauron, Sophie [2 ]
Jalenques, Isabelle [2 ]
机构
[1] CHU Clermont Ferrand, Serv Psychiat Adulte & Psychol Med, Clermont Ferrand, France
[2] Clermont Auvergne Univ, CHU Clermont Ferrand, CNRS, Inst Pascal,Serv Psychiat Adulte & Psychol Med,Cle, Clermont Ferrand, France
[3] CHU Clermont Ferrand, Direct Rech Clin & Innovat, Clermont Ferrand, France
[4] Clermont Auvergne Univ, CHU Clermont Ferrand, INSERM, Inst Pascal,Serv Dermatol,Clermont Auvergne INP, Clermont Ferrand, France
来源
PLOS ONE | 2023年 / 18卷 / 03期
关键词
INTERFERON-ALPHA THERAPY; TUMOR-NECROSIS-FACTOR; PERSONALITY-DISORDERS; DEPRESSIVE SYMPTOMS; HIGH PREVALENCE; SEX-DIFFERENCES; IMMUNE-SYSTEM; ANXIETY; ERYTHEMATOSUS; INFLAMMATION;
D O I
10.1371/journal.pone.0282079
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundSkin-restricted lupus is a chronic inflammatory disease associated with high rates of depression and anxiety disorders. Patients without psychiatric disorders can experience anxiety and depressive symptoms at a subclinical level, which could be risk factors for progression towards psychiatric disorders. It was decided, therefore, to investigate the presence of specific symptoms in skin-restricted lupus patients without axis I psychiatric disorders and their impact on the occurrence of axis I psychiatric disorders during the study follow-up. MethodsLongitudinal data of 38 patients and 76 matched controls without active axis I psychiatric disorders from the LuPsy cohort were used. Depressive, neurovegetative, psychic and somatic anxiety symptom scores were established from the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating scale (HAMA). ResultsNone of the participants had any current active axis I psychiatric disorders but the patients had personality disorders more frequently and had received more past psychotropic treatments than the controls. They also had higher MADRS and HAMA scores than the controls, in particular neurovegetative, psychic anxiety and somatic symptoms scores. No dermatological factor tested was associated with these scores, whereas being a lupus patient was associated with higher neurovegetative and somatic symptoms scores, having a current personality disorder with higher depressive and neurovegetative scores and receiving more past psychotropic treatments with psychic anxiety and somatic symptoms scores. The occurrence of psychiatric disorders during the study follow-up was associated with an elevated psychic anxiety score at baseline and past psychotropic treatment but not with history of psychiatric disorder. LimitationsThe LuPsy cohort included a large number of patients with axis I psychiatric disorders, the sample without axis I psychiatric disorders is therefore limited. ConclusionsWe observed numerous psychiatric symptoms among the skin-restricted lupus patients. They should therefore receive special attention in the management of their subclinical symptoms before they progress towards full psychiatric disorders.
引用
收藏
页数:16
相关论文
共 8 条
  • [1] Treatment of Psychiatric Disorders and Skin-Restricted Lupus Remission: A Longitudinal Study
    Jalenques, Isabelle
    Rondepierre, Fabien
    Massoubre, Catherine
    Labeille, Bruno
    Perrot, Jean-Luc
    Mulliez, Aurelien
    D'Incan, Michel
    JAMA DERMATOLOGY, 2017, 153 (12) : 1331 - 1332
  • [2] High prevalence of psychiatric disorders in patients with skin-restricted lupus: a case-control study
    Jalenques, I.
    Rondepierre, F.
    Massoubre, C.
    Haffen, E.
    Grand, J. P.
    Labeille, B.
    Perrot, J. L.
    Aubin, F.
    Skowron, F.
    Mulliez, A.
    D'Incan, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (05) : 1051 - 1060
  • [3] High Prevalence of Personality Disorders in Skin-restricted Lupus Patients
    Jalenques, Isabelle
    Rondepierre, Fabien
    Massoubre, Catherine
    Bonnefond, Sophie
    Schwan, Raymond
    Labeille, Bruno
    Perrot, Jean-Luc
    Collange, Marianne
    Mulliez, Aurelien
    D'Incan, Michel
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 941 - 946
  • [4] The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: a path analysis
    Shen, B.
    Feng, G.
    Tang, W.
    Huang, X.
    Yan, H.
    He, Y.
    Chen, W.
    Da, Z.
    Liu, H.
    Gu, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (01) : 101 - 107
  • [5] Axis I and II psychiatric disorders in patients with traumatic brain injury: A 12-month follow-up study
    Koponen, Salla
    Taiminen, Tero
    Hiekkanen, Heli
    Tenovuo, Olli
    BRAIN INJURY, 2011, 25 (11) : 1029 - 1034
  • [6] Study of DSM-IV Axis I psychiatric disorders in patients with refractory complex partial seizures using a short structured clinical interview
    Desai, Soaham D.
    Shukla, Garima
    Goyal, Vinay
    Singh, Sumit
    Padma, M. V.
    Tripathi, Manjari
    Srivastava, Achal
    Singh, Mamta
    Shivakumar, K.
    Sagar, Rajesh
    Behari, Madhuri
    EPILEPSY & BEHAVIOR, 2010, 19 (03) : 301 - 305
  • [7] A comparison of gains after treatment at a psychiatric outpatient clinic in patients with cluster A plus B, or cluster C personality disorders, and non- psychotic axis I disorders
    Narud, K
    Mykletun, A
    Dahl, AA
    NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 331 - 338
  • [8] Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
    Vikelis, Michail
    Dermitzakis, Emmanouil V.
    Xiromerisiou, Georgia
    Rallis, Dimitrios
    Soldatos, Panagiotis
    Litsardopoulos, Pantelis
    Rikos, Dimitrios
    Argyriou, Andreas A.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)